Alnylam Pharmaceuticals
ALNY
#618
Rank
C$43.38 B
Marketcap
$335.18
Share price
-10.08%
Change (1 day)
63.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $427.32 CAD on 2024-10-16

Lowest end of day price: $5.62 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$15.18-11.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$815.33-6.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$77.39-7.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.20-1.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.40-6.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$150.50-5.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$73.91-4.83%๐Ÿ‡ซ๐Ÿ‡ท France
$19.62-7.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel